Identifying and treating COPD in patients undergoing lung cancer evaluation is crucial. Early intervention could lead to better management of both diseases, improving health status, reducing healthcare costs, and potentially increasing survival rates.
This study aims to assess the impact of early diagnosis and optimal treatment of COPD on clinical outcomes in patients under evaluation for lung cancer. The study will combine information through an open-label RCT at the Lung Cancer Investigation Unit at Lillebaelt Hospital Vejle.
The findings could inform clinical practice by emphasizing the importance of integrated care approaches for patients with coexisting COPD and lung cancer, ultimately leading to better health outcomes.
Undergoing diagnostic evaluation for suspected lung cancer
Spirometry showing obstructive airflow limitation (FEV₁/FVC < 75 % or FEV₁ < 80 %, and no reversibility) at the first outpatient visit at the lung cancer evaluation
Presence of significant comorbidities that may interfere with diagnostic procedures or spirometry
Pregnant or breastfeeding women
Parallel
Tailored COPD consultations
Other interventionThese consultations will include assessment and treatment according to GOLD guidelines, including: Pharmacological management Smoking cessation support Referral to pulmonary rehabilitation as appropriate Referral for nutritional assessment and optimization when appropriate Referral to cardiovascular evaluation when appropriate Referral to sleep apnea evaluation when appropriate
CAT score
CAT consists of a questionnaire with eight items with the possibility of scoring 0-40 on respiratory symptoms. Participants will be tested at baseline, and after a follow-up period of 3 and 6 months after enrollment of the study.
Weight
kg Reviews the change
Height
cm
BMI
kg/m\^2 Reviews the change
1 min sit-to-stand-test
The higher the number the better
Click on the lead sponsor to view all of their trials.
Ditte Krag-Hansen
Lead sponsor
Region of Southern Denmark
Sponsor institution
AstraZeneca
Collaborator
Sygehus Lillebaelt
Collaborator
